Education Center

The Science Behind Monoclonal Antibodies: What Neurologists Need to Know

This content is sponsored by Amgen Inc. and Novartis Pharmaceuticals Corporation.

 

Click Here to Read the Content.

Topics in this content include:

  • Target-related and non-specific toxicity of therapeutic monoclonal antibodies (mAbs)
  • Research in antibody-based therapeutics
  • Differences between therapeutic mAbs and small-molecule therapies
USA-334-80408

Next Article: